Search

everythinglearnresearchcommunity

for

Search:↓

The compound (1R,2S)-4-(2-Cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile can stimulate hair growth and reduce oil production when applied topically.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

A new compound was created in 2010 that can control oil production when applied to the skin, and its effects are completely reversible after two weeks.

Finasteride reduces certain behaviors caused by D1-like receptor agonists but not by D2-like receptor agonists in mice.

5α-reductase inhibitors can interfere with doping tests by masking banned substances.

Clascoterone is a new, effective, and safe acne treatment without systemic side effects.

The document confirms the structures of major metabolites of the CRTh2 antagonist Setipiprant and identifies minor metabolites.

Ritlecitinib is the first FDA-approved pill for treating significant hair loss in alopecia areata patients aged 12 and up.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

The antibody 005-C04 blocks prolactin receptors, causing reversible infertility, impaired lactation, and hair regrowth in female mice.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

GI198745 is more potent and longer-lasting than finasteride, potentially better for treating hair loss.

Using existing drugs for new purposes could be a cost-effective way to treat chest pain and non-clogged heart arteries, with some drugs for lung blood pressure showing promise but needing more testing.

The inhibitor affects androgen metabolism but not ovarian function.

Neuroactive steroids affect cocaine's rewarding effects through the ς₁ receptor.

New steroidal compounds moderately block an enzyme related to testosterone conversion, less effectively than finasteride.

New compounds with carborane showed anti-androgen effects similar to flutamide.

The document concludes that adenosine receptor agonists have potential for treating various conditions, but only a few are approved due to challenges like side effects and the need for selective activation.

Compound 4 is a promising treatment for hair loss with low toxicity.

Combining dutasteride or finasteride with an α1 blocker is more effective for managing BPH than using either alone.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

Scientists made a chemical (compound 4e) that can be applied on skin to reduce oil production, which can help with acne, but it might cause skin sensitivity to light.

The retinoid receptor antagonist effectively disrupts vitamin A-related development in embryos.

Scientists made new substances that can block an enzyme linked to prostate issues and hair loss, with potential for creating a new treatment.

PRF lysates reduce inflammation in cancer cells and boost immune response in healthy oral cells.

Certain compounds, especially those with a propionic substituent, could potentially be new treatments for hair loss and similar disorders.

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

AKR1D1 controls glucocorticoid levels and receptor activity in liver cells.

Ch55 may help reduce skin scarring and fibrosis.

Strontium ranelate helps cartilage growth by blocking a specific cell pathway.